GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medical Developments International Ltd (ASX:MVP) » Definitions » Net Margin %
中文

Medical Developments International (ASX:MVP) Net Margin %

: -72.57% (As of Dec. 2023)
View and export this data going back to 2003. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Medical Developments International's Net Income for the six months ended in Dec. 2023 was A$-10.95 Mil. Medical Developments International's Revenue for the six months ended in Dec. 2023 was A$15.08 Mil. Therefore, Medical Developments International's net margin for the quarter that ended in Dec. 2023 was -72.57%.

The historical rank and industry rank for Medical Developments International's Net Margin % or its related term are showing as below:

ASX:MVP' s Net Margin % Range Over the Past 10 Years
Min: -57.65   Med: 3.33   Max: 13.17
Current: -57.65


ASX:MVP's Net Margin % is ranked worse than
80.77% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 3.77 vs ASX:MVP: -57.65

Medical Developments International Net Margin % Historical Data

The historical data trend for Medical Developments International's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medical Developments International Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.97 1.68 -49.72 -55.47 -17.44

Medical Developments International Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -76.88 -39.38 19.09 -45.32 -72.57

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Medical Developments International's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medical Developments International Net Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, Medical Developments International's Net Margin % distribution charts can be found below:

* The bar in red indicates where Medical Developments International's Net Margin % falls into.



Medical Developments International Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Medical Developments International's Net Margin for the fiscal year that ended in Jun. 2023 is calculated as

Net Margin=Net Income (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=-5.609/32.168
=-17.44 %

Medical Developments International's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-10.945/15.082
=-72.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medical Developments International  (ASX:MVP) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Medical Developments International Net Margin % Related Terms

Thank you for viewing the detailed overview of Medical Developments International's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Medical Developments International (ASX:MVP) Business Description

Traded in Other Exchanges
N/A
Address
4 Caribbean Drive, Scoresby, VIC, AUS, 3179
Medical Developments International Ltd is a specialized healthcare company. It manufactures and distributes the pharmaceutical drug and medical and veterinary equipment. The company provides a range of products in the areas of pain management, asthma, and resuscitation, plus veterinary equipment. It is organized into three business units: Pharmaceuticals, Medical Devices, and Veterinary products. Majority of its revenue comes from Pharmaceuticals Unit which engages in the sale of Penthrox within Australia, New Zealand, Europe the UK and some sales in Canada, the Middle East, Asia and South Africa.

Medical Developments International (ASX:MVP) Headlines

No Headlines